Shenzhen Chipscreen Biosciences Co Net debt/EBITDA
Cos'è Net debt/EBITDA di Shenzhen Chipscreen Biosciences Co?
Net debt/EBITDA di Shenzhen Chipscreen Biosciences Co., Ltd. è 5,565.30
Qual è la definizione di Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA di aziende nel Health Care settore su SSE rispetto a Shenzhen Chipscreen Biosciences Co
Cosa fa Shenzhen Chipscreen Biosciences Co?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Aziende con net debt/ebitda simili a Shenzhen Chipscreen Biosciences Co
- Mechel PJSC ha Net debt/EBITDA di 3,412.93
- MAN SE ha Net debt/EBITDA di 3,439.00
- Cresud ha Net debt/EBITDA di 3,527.59
- Dealnet Capital ha Net debt/EBITDA di 3,642.37
- EPI () ha Net debt/EBITDA di 4,336.87
- KT ha Net debt/EBITDA di 4,758.28
- Shenzhen Chipscreen Biosciences Co ha Net debt/EBITDA di 5,565.30
- Aemetis Inc ha Net debt/EBITDA di 6,195.62
- TTL Beteiligungs- und Grundbesitz-AG ha Net debt/EBITDA di 6,283.54
- Prospect Resources ha Net debt/EBITDA di 6,818.24
- Enel Chile S.A ha Net debt/EBITDA di 7,379.66
- Boeing Co ha Net debt/EBITDA di 7,664.71
- SK Telecom Co Ltd ha Net debt/EBITDA di 7,844.35